We assessed the ERK1/2 and Akt pathways, which are up-regulated frequently in other cancers [7, 39], through HIF-1α activity and found that the phosphorylation levels of ERK1/2 and Akt decreased, whereas ERK1/2 and Akt proteins were unchanged. This evidence concerns the gene AKT1 and cancer.